On Monday, Anavex Life Sciences Corporation (NASDAQ: AVXL) opened higher 6.15% from the last session, before settling in for the closing price of $12.35. Price fluctuations for AVXL have ranged from $3.25 to $14.44 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Company’s average yearly earnings per share was noted -16.03% at the time writing. With a float of $82.12 million, this company’s outstanding shares have now reached $84.80 million.
The firm has a total of 42 workers. Let’s measure their productivity. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Anavex Life Sciences Corporation (AVXL) Insider Activity
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Anavex Life Sciences Corporation is 3.18%, while institutional ownership is 31.88%. The most recent insider transaction that took place on Jun 14 ’24, was worth 10,319. In this transaction Director of this company bought 2,835 shares at a rate of $3.64, taking the stock ownership to the 5,000 shares. Before that another transaction happened on May 15 ’24, when Company’s Director bought 5,000 for $4.52, making the entire transaction worth $22,600. This insider now owns 5,000 shares in total.
Anavex Life Sciences Corporation (AVXL) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around -16.03% per share during the next fiscal year.
Anavex Life Sciences Corporation (NASDAQ: AVXL) Trading Performance Indicators
Check out the current performance indicators for Anavex Life Sciences Corporation (AVXL). In the past quarter, the stock posted a quick ratio of 8.86.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.51, a number that is poised to hit -0.15 in the next quarter and is forecasted to reach 2.35 in one year’s time.
Technical Analysis of Anavex Life Sciences Corporation (AVXL)
Analysing the last 5-days average volume posted by the [Anavex Life Sciences Corporation, AVXL], we can find that recorded value of 2.69 million was better than the volume posted last year of 2.65 million. As of the previous 9 days, the stock’s Stochastic %D was 68.34%. Additionally, its Average True Range was 1.16.
During the past 100 days, Anavex Life Sciences Corporation’s (AVXL) raw stochastic average was set at 86.01%, which indicates a significant increase from 78.47% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 142.97% in the past 14 days, which was higher than the 91.37% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $8.75, while its 200-day Moving Average is $5.92. Now, the first resistance to watch is $13.50. This is followed by the second major resistance level at $13.88. The third major resistance level sits at $14.45. If the price goes on to break the first support level at $12.55, it is likely to go to the next support level at $11.98. Should the price break the second support level, the third support level stands at $11.60.
Anavex Life Sciences Corporation (NASDAQ: AVXL) Key Stats
There are currently 84,816K shares outstanding in the company with a market cap of 1.13 billion. Presently, the company’s annual sales total 0 K according to its annual income of -43,000 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -11,620 K.
